Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma

Abstract

Objective To describe a case of radiation-induced uterine carcinosarcoma 6 years after a cervical squamous cell carcinoma treatment, which imposed some diagnostic and management challenges.

Case Report A 57-year-old woman with a history of pelvic chemoradiotherapy ∼ 6.5 years before the event described in this study, following an International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer, presented with a cervical mass, involving the uterine cavity, the cervical canal and the upper two thirds of the vagina. The biopsy showed a poorly differentiated carcinoma, and a positron emission tomography (PET) scan excluded distant metastasis, although it was unable to define the origin of the tumor as either a new primary malignancy of the endometrium/cervix or as a cervical recurrence. Surgical staging procedure was performed, and the diagnosis was endometrial carcinosarcoma, FIGO stage IIB. The patient was not able to complete the adjuvant therapy, and the progression of the disease was remarkable.

Conclusion The present case highlights one of the less common but more serious consequences of radiotherapy for cervical cancer, which has an increasing incidence in younger women, raising concerns about the long-term consequences of its management.

Keywords

carcinosarcoma - carcinogenesis - cervical cancer - radiation-induced neoplasms - uterine neoplasms

• References

• 1 Wallwiener C, Hartkopf A, Kommoss S. , et al. Clinical characteristics, surgical management and adjuvant therapy of patients with uterine carcinosarcoma: a retrospective case series. Geburtshilfe Frauenheilkd 2016; 76 (02) 188-193 Doi: 10.1055/s-0042-100205
• 2 Sando Z, Fouelifack FY, Fouogue JT, Fouedjio JH, Anoudem CE, Nangue C. Carcinosarcoma of the corpus uteri (Malignant Müllerian Mixed Tumor): a case report in Yaoundé (Cameroon). Pan Afr Med J 2013; 16: 145 Doi: 10.11604/pamj.2013.16.145.3497
• 3 Kahraman K, Ortac F, Kankaya D, Aynaoglu G. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report. Taiwan J Obstet Gynecol 2012; 51 (01) 89-92 Doi: 10.1016/j.tjog.2012.01.018
• 4 Koh WJ, Greer BE, Abu-Rustum NR. , et al; National Comprehensive Cancer Network. Uterine sarcoma, version 1.2016: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2015; 13 (11) 1321-1331
• 5 Hembree TN, Teer JK, Hakam A, Chiappori AA. Genetic investigation of uterine carcinosarcoma: case report and cohort analysis. Cancer Contr 2016; 23 (01) 61-66
• 6 Cherniack AD, Shen H, Walter V. , et al; Cancer Genome Atlas Research Network. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell 2017; 31 (03) 411-423 Doi: 10.1016/j.ccell.2017.02.010
• 7 Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65 (02) 87-108 Doi: 10.3322/caac.21262
• 8 Li S, Hu T, Lv W. , et al. Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group. Oncologist 2013; 18 (10) 1101-1107 Doi: 10.1634/theoncologist.2013-0123
• 9 Singh R. Review literature on uterine carcinosarcoma. J Cancer Res Ther 2014; 10 (03) 461-468 Doi: 10.4103/0973-1482.138197
• 10 Chaowawanit W, Tangjitgamo S. Uterine carcinosarcoma after pelvic radiotherapy. Clin Oncol 2016; 1: 1049